Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
KRRO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
KRRO
Korro Bio, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
KRRO
Korro Bio, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
KRRO
Korro Bio, Inc.
Change
16.49
· pre 16.49
· delayed
Mkt cap
$233.5M
Revenue
$1M
Q4 FY25
Revenue
$6M
FY25
LLY
ELI Lilly & Co
Change
1,417.89
· pre 1,429.00
· delayed
Pre-market
Nov 5 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Pre-market
Nov 5 '26
delayed
KRRO
Korro Bio, Inc.
vs
LLY
ELI Lilly & Co
16.49
pre 16.49
delayed
Price
1,417.89
pre 1,429.00
delayed
$233.5M
Mkt cap
$1.3T
Q4 FY25
$1M
Revenue
$24.4B
Q3 FY26
FY25
$6M
Revenue
$65.2B
FY25
Change
Change
KRRO
16.49
vs
LLY
1,417.89
Pre-market
Nov 5 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
KRRO, solid
LLY, dashed
Supply-chain overlap
Revenue flow
KRRO: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only KRRO
0
None
Shared
0
No disclosed counterparties: KRRO.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Role chip = supplier or customer
Source: SEC EDGAR